Our Mission
Our mission is to improve the life quality of patients depending on painful injectable drugs by offering them the OctoPatch® − a small painless patch that can be easily self-applied to the inner side of the cheek.
Our Mission
Our mission is to improve the life quality of patients depending on painful injectable drugs by offering them the OctoPatch® − a small painless patch that can be easily self-applied to the inner side of the cheek.
OBaris is selected for the Venture Leaders Biotech 2024!
OBaris is excited to share that we joined the Swiss National Startup Team! Represented by our CEO Da
04Apr
Transire Bio wins Venture Kick Stage III
OBaris wins Stage III Venture Kick and receives additional CHF 100’000! Read the announcement and le
27Mar
OBaris receives support from Gebert Rüf Foundation
OBaris receives CHF 150’000 for the accelerated market entry from Gebert Rüf Foundation! As a part o
12Mar
Supported by
